Log in to search using one of your social media accounts:

This page shows you the latest news items in this category.

Regeneron and Sanofi Announce Kevzara(R) (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA
New action date for Kevzara U.S. BLA is May 22, 2017 TARRYTOWN, N.Y. and PARIS, April 28, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administra... Biopharmaceuticals Regeneron Pharmaceuticals, Sanofi, Kevzara, sarilumab, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 28, 2017 Category: Pharmaceuticals Source Type: news

TfL launches badge to recognise customers with invisible impairments
(Source: TfL)Transport for London (TfL) has launched a‘Please offer me a seat’ badge to recognise customers with invisible impairments.The‘Please Offer Me a Seat’ badge and card was created following requests from customers, particularly those with invisible impairments, conditions and illnesses, who struggle to get a seat as their need for one isn’t immediately obvious.A six-week trial with 1,200 users was held in autumn last year to test if the badge and card would help people getting a seat. Over the course of the trial, participants’ confidence in using the network increased. More th...
Source: Arthritis Research UK - April 27, 2017 Category: Rheumatology Source Type: news

Can-Fite to begin Phase III trial of piclidenoson in Israel to treat rheumatoid arthritis
Biotechnology company Can-Fite BioPharma has obtained approval from the Institutional Review Board (IRB) of Barzilai Medical Center in Israel, to begin patient enrolment in the Phase III ACRobat clinical trial of piclidenoson for the treatment of rhe … (Source: Drug Development Technology)
Source: Drug Development Technology - April 26, 2017 Category: Pharmaceuticals Source Type: news

Cost controls help offset lower Amgen first-quarter drug sales
(Reuters) - Amgen Inc on Wednesday reported higher-than-expected first-quarter profit as cost controls helped offset a sharp drop in sales of Enbrel, its blockbuster rheumatoid arthritis and psoriasis drug. (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
Title: Early Treatment Equals Better Results for Rheumatoid ArthritisCategory: Health NewsCreated: 4/25/2017 12:00:00 AMLast Editorial Review: 4/26/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - April 26, 2017 Category: Rheumatology Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
Study found less disability, lower risk of early deathSource: HealthDay Related MedlinePlus Pages: Autoimmune Diseases, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 25, 2017 Category: Consumer Health News Source Type: news

Eli Lilly ’ s diabetes drugs boost Q1 revenue, earnings
Shares in Eli Lilly (NYSE:LLY) fell slightly today as the company met expectations on Wall Street with its 1st quarter financial results. The company has faced its share of issues in the last year – Lilly took a $150 million hit in November after its Alzheimer’s drug failed in a clinical trial and this month, the FDA rejected its rheumatoid arthritis drug. But the company’s diabetes therapies, such as Trulicity and Humalog, helped to propel the company to an adjusted quarterly profit that beat expectations on The Street. “We are encouraged by another solid performance from Lilly’s overall di...
Source: Mass Device - April 25, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Diabetes MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat Eli Lilly & Co. Source Type: news

Early Treatment Equals Better Results for Rheumatoid Arthritis
TUESDAY, April 25, 2017 -- Treating rheumatoid arthritis early may make for better outcomes, a new study suggests. Patients who were treated within six months of developing the first signs of the autoimmune disease did better in the long run and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 25, 2017 Category: Journals (General) Source Type: news

Sanofi and Regeneron ’s Kevzara receives CHMP opinion to treat Rheumatoid Arthritis
Regeneron Pharmaceuticals and Sanofi ’s Kevzara (sarilumab) has received a positive opinion from the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) to treat adult patients with moderately to severely active rheu… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 24, 2017 Category: Pharmaceuticals Source Type: news

Rheumatoid arthritis patients 'at an increased risk of atherosclerosis'
This study confirms increased prevalence of atherosclerosis in rheumatoid arthritis and provides data to support the hypothesis that patients have a high-risk plaque phenotype." Arthritis Research UK's view Dr Natalie Carter, head of research liaison and evaluation at Arthritis Research UK, said:"Rheumatoid arthritis is an incredibly debilitating condition that affects more than 400,000 people within the UK. The condition can not only limit a person's ability to live their everyday life to the full, but it can also put them at higher risk of cardiovascular disease. "This study not only reinforces the...
Source: Arthritis Research UK - April 24, 2017 Category: Rheumatology Source Type: news

Early Treatment Boosts Long-term Rheumatoid Arthritis Outcomes Early Treatment Boosts Long-term Rheumatoid Arthritis Outcomes
Early treatment boosts long-term arthritis outcomes and may be contributing to lower arthritis-related mortality, two new studies suggested.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Regeneron and Sanofi Receive Positive CHMP Opinion for Kevzara(R) (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis
TARRYTOWN, N.Y. and PARIS, April 24, 2017 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP... Biopharmaceuticals, Regulatory Regeneron Pharmaceuticals, Sanofi, Kevzara, sarilumab, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 24, 2017 Category: Pharmaceuticals Source Type: news

Early Treatment Boosts Long-Term Arthritis Outcome
Early Treatment Boosts Long-Term Rheumatoid Arthritis Outcomes (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 24, 2017 Category: Journals (General) Source Type: news

FDA approves Samsung Bioepis' copy of J & J's Remicade: company
SEOUL (Reuters) - South Korea's Samsung Bioepis Co Ltd said on Saturday the U.S. Food and Drug Administration approved its copy of Johnson& Johnson's rheumatoid arthritis drug Remicade, the first drug developed by the Samsung Group unit approved in the United States. (Source: Reuters: Health)
Source: Reuters: Health - April 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

EU Regulators OK Sarilumab (Kevzara) for Rheumatoid Arthritis EU Regulators OK Sarilumab (Kevzara) for Rheumatoid Arthritis
A committee of the European Medicines Agency also recommended approval of Erelzi, a biosimilar to entanercept that treats six different inflammatory disorders.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 21, 2017 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

FDA approves 2nd near-copy of Remicade for immune disorders
Federal regulators have approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders (Source: ABC News: Health)
Source: ABC News: Health - April 21, 2017 Category: Consumer Health News Tags: Health Source Type: news

EMA panel recommends nod for Sanofi, Regeneron's arthritis drug
(Reuters) - A European Medicines Agency panel said on Friday it recommended granting marketing approval to Sanofi and Regeneron's experimental drug to treat rheumatoid arthritis. (Source: Reuters: Health)
Source: Reuters: Health - April 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Patient-Reported Outcomes and MRI Measures in RA Patient-Reported Outcomes and MRI Measures in RA
Are MRI measures associated with patient-reported outcomes among those with rheumatoid arthritis?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 21, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Studies examine rheumatoid arthritis patients' prognosis
(Wiley) What's the long-term outlook for today's patients with early rheumatoid arthritis? A new study in Arthritis& Rheumatology that looks at patients' mortality, disease activity, and physical function over the course of 20 years reveals the importance of early treatment. Another study in the journal notes that deaths from arthritis are declining. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 20, 2017 Category: Global & Universal Source Type: news

Rheumatoid arthritis medications: Dangerous during pregnancy?
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - April 20, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis cure: Symptoms halted by doing THIS (it could prevent joint damage)
RHEUMATOID ARTHRITIS sufferers have been sent a lifeline thanks to a new study which found early treatment can reduce symptoms for years afterwards. (Source: Daily Express - Health)
Source: Daily Express - Health - April 19, 2017 Category: Consumer Health News Source Type: news

Rheumatoid arthritis patients 'have experienced progress in recent decades'
This study confirms how important early diagnosis and the commencement of treatment is. It is also encouraging to hear about the progress that has been made over the last 20 years. "Now the scientific community must continue to build on this, so that together we can continue to harness the power of exceptional science and make everyday life better for all people with arthritis." (Source: Arthritis Research UK)
Source: Arthritis Research UK - April 18, 2017 Category: Rheumatology Source Type: news

RA Patients May Benefit From Using a Pedometer RA Patients May Benefit From Using a Pedometer
Patients with rheumatoid arthritis (RA) who receive pedometers may be more active and feel less fatigued even if they are not told to use the trackers to aim for a specific number of steps, a small study suggests.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - April 18, 2017 Category: Orthopaedics Tags: Rheumatology News Source Type: news

US FDA declines approval of Eli Lilly and Incyte ’s baricitinib drug to treat RA
Eli Lilly and partner Incyte have announced that the US Food and Drug Administration (FDA) has declined to approve a new drug, baricitinib, to treat moderate-to-severe rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 17, 2017 Category: Pharmaceuticals Source Type: news

FDA Says ' No ' to Baricitinib for Rheumatoid Arthritis
(MedPage Today) -- Dosages and safety were noted as concerns (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 17, 2017 Category: American Health Source Type: news

Tofacitinib for Rheumatoid Arthritis and Plaque Psoriasis Tofacitinib for Rheumatoid Arthritis and Plaque Psoriasis
Review the latest data on the oral immunosuppressant tofacitinib, recently approved for the treatment of rheumatoid arthritis, and currently in Phase III trials for treating chronic plaque psoriasis.Skin Therapy Letter (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Unichem Labs gets USFDA nod for arthritis drug
Piroxicam is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 17, 2017 Category: Pharmaceuticals Source Type: news

Rheumatoid arthritis and cardiovascular risk: Mayo Clinic Radio Health Minute
In this Mayo Clinic Radio Health Minute, we hear from Dr. Eric Matteson on the increased cardiovascular risk for women with rheumatoid arthritis. To listen, click the link below. RA and CV Risk (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 17, 2017 Category: Databases & Libraries Source Type: news

Pedometers tied to less fatigue for rheumatoid arthritis patients
(Reuters Health) - Patients with rheumatoid arthritis who receive pedometers may be more active and feel less fatigued even if they are not told to use the trackers to aim for a specific number of steps, a small study suggests. (Source: Reuters: Health)
Source: Reuters: Health - April 14, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. FDA Issues Complete Response Letter for Baricitinib
INDIANAPOLIS, April 14, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for th... Biopharmaceuticals, FDA Eli Lilly, Incyte, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2017 Category: Pharmaceuticals Source Type: news

U.S. FDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday declined to approve a new drug for rheumatoid arthritis made by Eli Lilly and Co and partner Incyte Corp, the companies said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - April 14, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Diet and Risk for Rheumatoid Arthritis Diet and Risk for Rheumatoid Arthritis
Dr Kevin Deane highlights a new study exploring how a healthy diet can influence the risk of developing rheumatoid arthritis.Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 11, 2017 Category: Consumer Health News Tags: Rheumatology Viewpoint Source Type: news

Obesity influences rheumatoid arthritis diagnostic tests
Obesity causes patients to receive higher scores in blood tests used to diagnose rheumatoid arthritis even if they do not have the condition, researchers have warned. (Source: GP Online News)
Source: GP Online News - April 11, 2017 Category: Primary Care Tags: 15.9 Rheumatology, Musculoskeletal and Trauma Source Type: news

Palindromic rheumatism: Precursor to rheumatoid arthritis?
(Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - April 11, 2017 Category: Consumer Health News Source Type: news

Medicare Monday: What they are saying about MedPAC ’s Part B recommendations
Last week, the Medicare Payment Advisory Commission (MedPAC) voted on a number of recommendations affecting Medicare Part B. These proposed changes could negatively impact patients ’ access to Part B medicines that are used to treat complex and serious conditions, like cancer, rheumatoid arthritis and mental illness, among others. In case you missed it, we looked at theserecommendations ahead of the vote. (Source: The Catalyst)
Source: The Catalyst - April 10, 2017 Category: Pharmaceuticals Tags: Medicare Medicare Monday Part B Source Type: news

Rheumatoid arthritis tougher to spot, track in obese patients
Blood tests to diagnose and monitor rheumatoid arthritis may be thrown off by obesity in women, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 10, 2017 Category: Consumer Health News Source Type: news

Obesity May Make Rheumatoid Arthritis Tough to Spot
Inflammation from excess weight could lead doctors to think disease is worse in women than it is, study finds (Source: WebMD Health)
Source: WebMD Health - April 10, 2017 Category: Consumer Health News Source Type: news

This is not a special effect: New video shows the destruction of a rogue cell
In the latest video of ourCells series, part of the GOBOLDLY ™ campaign, we witness the destruction of a rogue cell that causes rheumatoid arthritis (RA), a disease that affects 1.3 million Americans. (Source: The Catalyst)
Source: The Catalyst - April 10, 2017 Category: Pharmaceuticals Tags: Rheumatoid Arthritis GoBoldly Source Type: news

Obesity May Make Rheumatoid Arthritis Tough to Spot, Track
Inflammation from excess weight could lead doctors to think disease is worse in women than it is, study finds Source: HealthDay Related MedlinePlus Pages: Obesity, Rheumatoid Arthritis, Women's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - April 10, 2017 Category: Consumer Health News Source Type: news

Obesity May Make Rheumatoid Arthritis Tough to Spot, Track
MONDAY, April 10, 2017 -- Blood tests to diagnose and monitor rheumatoid arthritis may be thrown off by obesity in women, a new study suggests. " Physicians might assume that high levels of inflammation mean that a patient has rheumatoid arthritis... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 10, 2017 Category: Journals (General) Source Type: news

Obesity May Make Rheumatoid Arthritis Tough to Spot, Track
Title: Obesity May Make Rheumatoid Arthritis Tough to Spot, TrackCategory: Health NewsCreated: 4/10/2017 12:00:00 AMLast Editorial Review: 4/10/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - April 10, 2017 Category: Rheumatology Source Type: news

Obesity may skew results of rheumatoid arthritis blood tests in women
Doctors should factor this in when using these tests, say researchers Related items fromOnMedica Breastfeeding may halve rheumatoid arthritis risk Drug for rheumatoid arthritis appears to have effect on severe eczema Transforming MSK care and patient outcomes If an anti-TNF fails to treat RA, try a non-TNF biologic Experts criticise arthritis patient referral delays (Source: OnMedica Latest News)
Source: OnMedica Latest News - April 10, 2017 Category: UK Health Source Type: news

RA medicines often demonstrate far greater benefits to patients than initially understood
In thelast decade, new therapies to treat rheumatoid arthritis (RA), a progressive and painful autoimmune disorder, have expanded patients ’ treatment options and significantly improved outcomes, helping people with RA achieve disease remission, avoid disability and experience an improved quality of life. And since the approval of these therapies and biologics, clinical evidence has grown, and these treatments are demonstrating far g reater benefits to patients than understood at the time of their initial approval. (Source: The Catalyst)
Source: The Catalyst - April 5, 2017 Category: Pharmaceuticals Tags: Value Rheumatoid Arthritis Value-Driven Health Care The Value Collaborative Source Type: news

Pedometers increase activity and decrease fatigue in rheumatoid arthritis patients
(Wiley) Providing pedometers, with and without providing step targets, to individuals with rheumatoid arthritis increased activity levels and decreased fatigue in a recent study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 5, 2017 Category: Global & Universal Source Type: news

British Society of Rheumatology Prizes - Congratulations!
Michael Mason PrizeWe would like to say congratulations to Dr Francesca Barone (University of Birmingham) for being awarded theMichael Mason Prize by the British Society of Rheumatology. This prize is awarded by the Herberden Committee for excellence in clinical or scientific research in the field of rheumatology.Dr Francesca Barone holds anArthritis Research UK senior research fellowship. She is working to improve understanding of Sjögren’s syndrome, by looking at tertiary lymphoid organs that reside in the salivary glands. As well as answering why these structures are present, and whether removal of these stru...
Source: Arthritis Research UK - April 3, 2017 Category: Rheumatology Source Type: news

April 2017
Painful Joints?: Early Treatment for Rheumatoid Arthritis Is Key...Keep Your Voice Sound: How to Prevent and Avoid Voice Problems...Reducing Underage Drinking Among American Indians...How Cancer Cells Spread in the Body...Featured Web Site: Understanding Drug-Supplement Interactions (Source: NIH News in Health)
Source: NIH News in Health - March 31, 2017 Category: Consumer Health News Source Type: news

What Is RA? Consequences of Changed Classification Criteria What Is RA? Consequences of Changed Classification Criteria
What are the potential consequences of new classification criteria for rheumatoid arthritis?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 31, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Get Good Gut Health With Prebiotics And Probiotics
We all want our gut to feel good. No one wants a gut that is in constant turmoil possibly leading to serious conditions of Crohn’s disease, ulcerative colitis, diabetes, obesity or rheumatoid arthritis. What our gut is trying to tell us when these diseases arise is that the gut’s microbiome, partly inherited from your mother at birth and partly determined by your lifestyle, have a great deal of influence on our health. Our gut microbiome is made of up bacteria, all good, that live within our intestines helping us digest our food. Digestion is serious business as these microbes munch away making essential vitami...
Source: Healthy Living - The Huffington Post - March 30, 2017 Category: Consumer Health News Source Type: news